Skip to main content

From conversation to source of truth.

Watch what the peptide world is saying, then see what the published evidence actually supports. Community experience stays clearly separate from research.

Watch

See what's happening.

The freshest relevance-ranked video intelligence from the peptide world — real creators, summarised and cross-linked to the compounds they discuss. Playback stays inside PEPTD.

  • Thymosin Alpha-1

Thymosin Alpha-1 vs COVID-19

LookingGlass ResearchOct 9, 2026

Why it matters · PEPTD AI summary

This video examines Thymosin Alpha-1's potential role in severe infection, specifically discussing a 2020 retrospective study from Wuhan on 76 severe COVID-19 cases. The study reported on mortality, T-cell counts, and T-cell exhaustion markers in individuals receiving Thymosin Alpha-1. The creator also contextualizes these findings with a larger multicenter retrospective study.

Creator commentaryYouTube · plays inside PEPTD
Watch
  • Retatrutide
  • BPC-157

Peptide Update - Q&A: BioRegulators, Cerebrolysin, GHRP6, Retatrutide, IM vs SubQ, HGH & More...

Joshua Smith - GSD ModeOct 4, 2026

Why it matters · PEPTD AI summary

This YouTube video features a Q&A session discussing various peptides, including Retatrutide, Cerebrolysin, GHRP6, Ipamorelin, Tirzepatide, MOTS-c, and Tesamorelin. The discussion also covers related topics such as GLP-1s, HGH, TRT, peptide administration methods (IM vs. SubQ), and their potential applications for weight loss, muscle gain, and recovery. The creator interprets information and responds to community questions.

Creator commentaryYouTube · plays inside PEPTD
Watch

Learn

Understand what the evidence says.

One subject at a time, translated into a graded intelligence card: what the research supports, what is still open, and where the sources are.

Learn intelligence card · Healing

BPC-157

Clinical Trial Only

Takeaway

Studied in animal models for tissue repair. Human evidence is limited.

  • Peer-reviewed research3 studies
  • Clinical registry2 trials
  • Creator commentary401 video briefings

What we know

  • Reported in preclinical studies to influence angiogenesis, growth factor expression, and nitric oxide pathways involved in tissue repair.

What remains uncertain

  • Long-term human safety, optimal route of administration, and effective dose ranges are not established.

Known risks · Not approved for human use by FDA. Human safety data is limited.

Key indexed sources

  • Registered trialBPC 157 for Acute Hamstring Muscle Strain Repair
  • Registered trialA Clinical Trial to Evaluate the Effects of Peptide Gummies on Markers of Inflammation, Physical Performance, and Recovery
  • Peer-reviewedEffects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.

Reviewed Jun 13, 2026Educational summary · not medical advice

Industry Pulse

Questions moving through the peptide world.

Recurring public questions and concerns, paraphrased and routed to the video, research or tool that actually helps.

From public discussions · Summarised from public peptide discussions. Not posted by PEPTD members, and not medical evidence.

Common questionReconstitution & dosing math

How do I know whether my reconstitution math is actually right?

Reconstitution math is one of the most persistent sources of confusion in public peptide discussions — people repeatedly ask others to sanity-check mg, mL and syringe-unit conversions before drawing anything.

ReconstitutionSyringe unitsBeginner

From public discussions · Summarised from public peptide discussions. Not posted by PEPTD members, and not medical evidence.

Captured from r/Peptidesource

Watch · Learn · Build

Then make it yours.

Save what matters, follow the subjects you care about, build your own stack, and share it with a link that leads straight back to the source.

Join PEPTD — it's free to start